Stephen E Lankenau
Overview
Explore the profile of Stephen E Lankenau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fedorova E, Wong C, Conn B, Ataiants J, Lankenau S
J Drug Issues
. 2024 Apr;
53(3):422-430.
PMID: 38603185
It is crucial to understand COVID-19 vaccine uptake and attitudes among young adult cannabis users given the lowest vaccination rates among young adults and negative association between cannabis use and...
2.
Ataiants J, Wong C, Odejimi O, Fedorova E, Conn B, Lankenau S
Am J Drug Alcohol Abuse
. 2024 Feb;
50(2):229-241.
PMID: 38407837
In 2016, California transitioned from legalized medical cannabis use to adult-use. Little is known about how this policy change affected medicinal cannabis use among young adults. To identify longitudinal groups...
3.
Fedorova E, Mitchel A, Finkelstein M, Ataiants J, Wong C, Conn B, et al.
J Psychoactive Drugs
. 2023 Nov;
57(1):99-109.
PMID: 37997888
Cannabis was legalized for adult use in California in 2016 for individuals 21 and older. Among 18-20-years-olds, who can possess cannabis legally as medical cannabis patients (MCP) but not as...
4.
Conn B, Brammer W, Choi S, Fedorova E, Ataiants J, Lankenau S, et al.
Subst Use Misuse
. 2023 Oct;
59(2):193-207.
PMID: 37822106
Background: While growing evidence has identified mental and physical health-related cannabis use motives as significant mechanisms between childhood trauma and problematic cannabis use (PCU) for emerging adults (EA), there is...
5.
DiGuiseppi G, Fedorova E, Conn B, Lankenau S, Davis J, Ataiants J, et al.
Cannabis
. 2023 Jun;
6(1):20-33.
PMID: 37287728
Introduction: As the COVID-19 pandemic has caused historic morbidity and mortality and disrupted young people's social relationships, little is known regarding change in young adults' social cannabis use following social...
6.
DiGuiseppi G, Fedorova E, Lankenau S, Davis J, Wong C
J Stud Alcohol Drugs
. 2022 Dec;
83(6):802-811.
PMID: 36484577
Objective: Social factors play an important role in young adults' substance use behaviors, but little is known about how egocentric social network factors are related to young adults' cannabis use....
7.
Ng-Cordell E, Rai A, Peracha H, Garfield T, Lankenau S, Robins D, et al.
Front Psychiatry
. 2022 Aug;
13:825008.
PMID: 35911211
Background: Coping can moderate the relationship between trauma exposure and trauma symptoms. There are many conceptualisations of coping in the general population, but limited research has considered how autistic individuals...
8.
Fedorova E, Wong C, Conn B, Ataiants J, Iverson E, Lankenau S
J Drug Issues
. 2022 Apr;
52(2):207-224.
PMID: 35382397
Few qualitative studies have examined the impact of COVID-19 on cannabis and alcohol use, and overall well-being among cannabis users. Cannabis users (aged 26-32) were surveyed quantitatively (n=158) and interviewed...
9.
Scheidell J, Ataiants J, Lankenau S
Subst Use Misuse
. 2022 Mar;
57(6):999-1006.
PMID: 35277115
Reproductive health research among women who use drugs has focused on pregnancy prevention and perinatal/neonatal outcomes, but there have been few investigations of miscarriage and abortion, including prevalence and associated...
10.
Brammer W, Conn B, Iverson E, Lankenau S, Dodson C, Wong C
Subst Use Misuse
. 2022 Feb;
57(5):684-697.
PMID: 35193442
: Despite evidence of the contribution of childhood trauma to the development of problematic cannabis use, its mediating pathways are largely unknown. Given the link between cannabis motives with trauma...